Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants
- 6 March 2023
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 22 (3) , 331-339
Abstract
Acute myeloid leukemia with germline CEBPA mutation is a subtype of acute myeloid leukemia that is associated with a favorable prognosis. Most of the reported cases of acute myeloid leukemia with CEBPA germline variants involve a germline variant in the N-terminus and a somatic variant in the C-terminus. There are only a few reported cases where the CEBPA germline variant has been identified in the C-terminus and the somatic variant in the N-terminus. This case report and review of the literature illustrates that, although acute myeloid leukemia with CEBPA N- or C-terminal germline variants have certain similarities such as atypically young age at diagnosis, frequent relapse, and favourable overall prognosis, there are also significant differences such as lower life-time penetrance of acute myeloid leukemia and shorter time to relapse for germline C-terminal cases. These findings add important information on the natural history and clinical outcomes of acute myeloid leukemia with germline CEBPA C-terminal variants and these findings should be considered in the management of patients and their family members.Keywords
All Related Versions
This publication has 14 references indexed in Scilit:
- Companion gene mutations and their clinical significance in AML with double mutant CEBPACancer Gene Therapy, 2019
- Germline CEBPA mutations in Korean patients with acute myeloid leukemiaLeukemia Research, 2019
- Genetic predisposition to hematologic malignancies: management and surveillanceBlood, 2017
- Familial CEBPA-mutated acute myeloid leukemiaSeminars in Hematology, 2017
- Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large familyHaematologica, 2015
- Disease evolution and outcomes in familial AML with germline CEBPA mutationsBlood, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- A novel CCAAT/enhancer binding protein α germline variant in a case of acute myeloid leukemiaLeukemia & Lymphoma, 2012
- First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantationBlood, 2011
- Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entityBlood, 2011